Prosecution Insights
Last updated: April 19, 2026

Examiner: SCHLIENTZ, NATHAN W

Tech Center 1600 • Art Units: 1616

This examiner grants 41% of resolved cases

Performance Statistics

41.0%
Allow Rate
-19.0% vs TC avg
855
Total Applications
-20.6%
Interview Lift
1357
Avg Prosecution Days
Based on 795 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
19.4%
§102 Novelty
41.7%
§103 Obviousness
22.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17793475 GLUFOSINATE FORMULATIONS CONTAINING AMINES OR AMMONIUM SALTS Final Rejection BASF SE
19096361 PLANT DEFENSE INDUCER Final Rejection KATHOLIEKE UNIVERSITEIT LEUVEN
18598213 PERSONAL CARE COMPOSITIONS FOR CLEANSING THE SKIN Non-Final OA The Procter & Gamble Company
19067410 PLANT PRIMING COMPOSITIONS AND METHODS OF USE THEREOF Non-Final OA ZERO GRAVITY SOLUTIONS, INC.
18834973 PLANT PRIMING COMPOSITIONS AND METHODS OF USE THEREOF Final Rejection ZERO GRAVITY SOLUTIONS, INC.
17792607 HERBICIDE COMPOSITIONS COMPRISING DICAMBA MONOETHANOLAMINE SALT AND A PPO-INHIBITOR Non-Final OA MONSANTO TECHNOLOGY LLC
16922121 AQUEOUS CONCENTRATED HERBICIDAL COMPOSITIONS CONTAINING GLYPHOSATE SALTS AND DICAMBA SALTS Non-Final OA Monsanto Technology LLC
18558394 LIQUID CHEMICAL STERILIZATION CHEMISTRY Non-Final OA Medivators Inc.
18599375 SEPARATING MEMBRANE FOR DENTISTRY AND METHOD FOR MANUFACTURING THE SAME Non-Final OA NAN YA PLASTICS CORPORATION
17232710 COMPOSITIONS AND METHODS FOR DIFFERENTIAL RELEASE OF 1-METHYLCYCLOPROPENE Final Rejection Verdant Technologies, LLC
17273204 SURFACTANT COMPOSITION AND USE THEREOF Non-Final OA RHODIA OPERATIONS
17251128 LIQUID AND STORAGE-STABLE FORMULATIONS FOR FUNGAL SPORES Final Rejection Danstar Ferment AG
18701226 Bioactive Coating for Topical Application, Process for its Preparation and use of the Bioactive Coating Non-Final OA GLOBAL NEW SKIN COSMETICS GMBH
18598151 Steroidal Testosterone Ester Compositions and Preparation Thereof Non-Final OA Lipocine Inc.
18597414 MAKE-UP PRODUCT Non-Final OA CHROMAVIS S.p.A.
18596418 DIETARY SUPPLEMENT BEADS Non-Final OA Phi Health Sciences, Inc.
17597385 TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE AGENT-CONTAINING LAYER COMPRISING A SILICONE-CONTAINING POLYMER AND A SKIN CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVE Non-Final OA LTS LOHMANN THERAPIE-SYSTEME AG
18323539 ENHANCEMENT OF PEANUT (GROUNDNUT) SEED HEALTH BENEFITS BY BOOSTING RESVERATROL CONTENT Final Rejection The United States of America, as represented by the Secretary of Agriculture
18413556 ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS Final Rejection Aquestive Therapeutics, Inc.
17549219 ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS Final Rejection AQUESTIVE THERAPEUTICS, INC.
18262277 EFFERVESCENT GERMICIDAL COMPOSITIONS Final Rejection Reckitt & Colman (Overseas) Hygiene Home Limited
18578881 RNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES AND ITS FORMULATIONS Non-Final OA Gennova Biopharmaceuticals Limited
18269182 COATING AGENT BASED ON A COPPER-NANOPARTICLE BIOHYBRID AND USE THEREOF AS A BIOCIDAL AGENT Non-Final OA INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD (IACS)
18557024 AGRICULTURAL AND HORTICULTURAL FUNGICIDAL COMPOSITION Non-Final OA Nippon Soda Co., Ltd.
18379301 DISINFECTANT, ANTI-INFECTIVE FIBROUS MATERIAL, ANTI-INFECTIVE FIBROUS PRODUCT, METHOD FOR PRODUCING THE SAME, AND APPARATUS FOR PRODUCING THE SAME Final Rejection SUSUME CO., LTD.
18276543 An antifungal composition comprising natamycin and at least one insecticide Final Rejection Ceradis Patent B.V.
18018371 GENETICALLY MODIFIED CELL LINES EXPRESSING AN EXOGENOUS SUBSTANCE AND USES THEREOF Non-Final OA SIGILON THERAPEUTICS, INC.
17908624 STERILIZATION COMPOSITIONS AND METHODS FOR USING THEREOF Final Rejection Save Foods Ltd.
17759260 NANOTECHNOLOGY-BASED PESTICIDES AND INTERMEDIATES, COMPOSITIONS AND TREATMENTS USING THE SAME Final Rejection East Carolina University
17625831 LONG-LASTING FORMULATION CONTAINING RIVASTIGMINE, AND METHOD FOR PREPARING SAME Final Rejection G2GBIO, INC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month